XDH and cancer: Mechanistically, the increase in the levels of hypoxanthine and xanthine might be the result of the cancer-associated downregulation of xanthine oxidoreductase (XOR), the enzyme that catalyzes the conversion of xanthine and hypoxanthine to uric acid [29].